Structural modelling predicts that fibrocystin destabilisation is a pathogenic cause of ARPKD
Travis Bannell, Naveen Mathew, Kathrin Burgmaier…·Joseph J. B. Cockburn
The paper uses structural modeling to show that fibrocystin destabilization due to PKHD1 missense mutations is a key pathogenic mechanism in ARPKD, suggesting stabilization as a therapeutic target.